Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Montelukast sodium, the active ingredient

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Montelukast Sodium Manufacturers in India Suppliers Montelukast Sodium Exporters Distributors Montelukast Sodium api active pharmaceuticals ingredients Montelukast Sodium manufacturers Side Effects bulk drugs raw material Montelukast Sodium companies Side Effects Importers Montelukast Sodium Montelukast Sodium Exporters Montelukast Sodium exporters FDA Montelukast Sodium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Montelukast Sodium manufacturing pharmaceutical drugs pharmaceutical intermediates Montelukast Sodium pharmaceutical chemicals pharmaceutical raw materials Montelukast Sodium active pharmaceutical ingredients Montelukast Sodium committee active pharmaceutical ingredients manufacturer Montelukast Sodium Active Pharmaceutical Ingredients manufacturer Montelukast Sodium exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Montelukast Sodium, Montelukast Sodium manufacturer India, Montelukast Sodium product, Montelukast Sodium products, Api preparation, Certificate of Analysis API manufacturer product, Montelukast Sodium anti ulcer product, Certificate of Origin COA Montelukast Sodium COS Montelukast Sodium, pharmaceutical generic, pharmaceutical drug, medical, Montelukast Sodium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Montelukast Sodium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Montelukast Sodium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Montelukast Sodium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Montelukast Sodium ingredients, api, HIV Montelukast Sodium, tablets, capsules, syrup & protein Montelukast Sodium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Montelukast Sodium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Montelukast Sodium WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

eye


















 

 







 

 

HOME >> Pharmaceuticals API List 2 >> Montelukast Sodium >> Drug Description

Montelukast Sodium CAS number 158966-92-8

DRUG DESCRIPTION
Montelukast Sodium CAS number 158966-92-8

Singulair is a medicine called a leukotriene receptor antagonist. It works by blocking substances in the body called leukotrienes. Blocking leukotrienes improves asthma and allergic rhinitis.

Singulair is prescribed for the treatment of asthma, the prevention of exercise-induced asthma, and allergic rhinitis (sneezing, stuffy nose, runny nose, itching of the nose, and outdoor and indoor allergies).

Montelukast sodium, the active ingredient in , is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.

Montelukast sodium is described chemically as [R -(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1 methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid, monosodium salt.

The empirical formula is C35H35ClNNaO3S, and its molecular weight is 608.18.
Montelukast sodium is a hygroscopic, optically active, white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile.

Each 10-mg film-coated  tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, and magnesium stearate. The film coating consists of: hydroxypropyl methylcellulose, hydroxypropyl cellulose, titanium dioxide, red ferric oxide, yellow ferric oxide, and carnauba wax.

Each 4-mg and 5-mg chewable  tablet contains 4.2 and 5.2 mg montelukast sodium, respectively, which are equivalent to 4 and 5 mg of montelukast, respectively. Both chewable tablets contain the following inactive ingredients: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, red ferric oxide, croscarmellose sodium, cherry flavor, aspartame, and magnesium stearate.

Each packet of  4-mg oral granules contains 4.2 mg montelukast sodium, which is equivalent to 4 mg of montelukast.

The oral granule formulation contains the following inactive ingredients: mannitol, hydroxypropyl cellulose, and magnesium stearate.

Information Associated with Product:
DRUG DESCRIPTION >>
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Montelukast Sodium

More Api at Taj Pharmaceuticals Ltd.

Lacidipine

Lamotrigine

Lansoprazole

Levetiracetam

Levo Cetirizine

Levofloxacin

Loratadine

Losartan Potassium

Metoprolol Succinate

Montelukast Sodium

Moxifloxacin HCl

Naproxen

Naratriptan

Norfloxacin

Nizatidine

Olmesartan

Omeprazole

Omeprazole Sodium

Oxaprozin

Paroxetine

Pantoprazole

Primidone

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.